Abacus Medicine Pharma Services Ltd
Registered name: ABACUS MEDICINE PHARMA SERVICES LTD
Part of Abacus Medicine Pharma Services Aps groupAbacus Medicine Pharma Services Ltd made £6.3m revenue and £348k profit in the year to 31 Dec 2025. read from filing text
Abacus Medicine Pharma Services Ltd’s revenue fell 69% to £6.3m in the year to 31 Dec 2025, with £348k profit and 21 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Farnborough; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Farnborough, South East
- Age
- 12 yrs · since 2013
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The immediate parent company is Abacus Medicine Pharma Services ApS, a company incorporated in Denmark.”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2022 | 31 Dec 2023 | 31 Dec 2024 | 31 Dec 2025 |
|---|---|---|---|---|
| Disclosure | Profit only | Full P&Lread from filing text | Full P&Lread from filing text | Full P&Lread from filing text |
| Profit & loss | ||||
| Revenue (turnover) | — | £30.5m | £20.4m | £6.3m |
| Cost of sales | — | £27.7m | £16.7m | £3.1m |
| Gross profit | — | £2.9m | £3.8m | £3.2m |
| Operating profit | — | −£742k | £8.6m | £761k |
| Profit before tax | — | −£1.5m | £8.1m | £348k |
| Profit after tax | −£2m | −£1.5m | £7.7m | £348k |
| Profit (best available) | −£2m | −£1.5m | £7.7m | £348k |
| Staff costs | — | £3.2m | £2.2m | £2.2m |
| Employees (average) | 20 | 22 | 23 | 21 |
| Ratios | ||||
| Profit margin | — | −4.9% | 37.7% | 5.5% |
| Gross margin | — | 9.4% | 18.4% | 50.6% |
| Revenue per employee | — | £1.4m | £889k | £299k |
| Profit per employee | −£97.8k | −£67.7k | £335k | £16.6k |
| Growth (year on year) | ||||
| Revenue growth | — | — | ▼33.1% | ▼69.3% |
| Profit growth | — | — | — | ▼95.5% |
| Headcount growth | — | ▲10% | ▲4.5% | ▼8.7% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £490k | £3.2m | £5m | £0 |
| Net assets | −£6.3m | −£7.8m | −£31.3k | £330k |
| Fixed assets | £0 | £0 | £0 | £0 |
| Current assets | £4.7m | £5.8m | £7.4m | £2m |
| Debtors | £200k | £46.4k | £60.6k | £123k |
| Deferred income | — | £708k | £460k | £848k |
| Source | FullAccounts · bulk data Jun 2024 | FullAccounts · bulk data Jun 2024 | FullAccounts · bulk data Jul 2025 | FullAccounts · bulk data Jun 2026 |
How the business works
- Profit margin
- 5.5%
- Profit ÷ revenue.
- Gross margin
- 50.6%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £299k
- Revenue ÷ average employees.
- Profit per employee
- £16.6k
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 0%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 13.5%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 2%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- —
- Now £330k
- Cash at bank
- ▼100%
- Now £0
- Headcount
- ▼9%
- Now 21
- Deferred income
- ▲84%
- Now £848k
- Fixed assets
- —
- Now £0
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Ownership chain
- Abacus Medicine Pharma Services Aps (registered outside the UK register)ultimate parent75–100%
- Abacus Medicine Pharma Services Ltdthis company
Bands show the share of ownership each company holds in the one below it.
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Recordati Rare Diseases UK LimitedMaidenhead · Wholesale of pharmaceutical goods
- Revenue
- £6.4m
- Profit
- £123k
- Staff
- 9
- Apellis UK LimitedLondon · Wholesale of pharmaceutical goods
- Revenue
- £4.7m
- Profit
- £127k
- Staff
- 11
- Ananta Medicare LtdFulham London · Wholesale of pharmaceutical goods
- Revenue
- £4.7m
- Profit
- £90.9k
- Staff
- 3
- Arena Pharmaceuticals LimitedBuckingham · Wholesale of pharmaceutical goods
- Revenue
- £4.5m
- Profit
- £394k
- Staff
- 3
- Medicom Healthcare LimitedKings Cross · Wholesale of pharmaceutical goods
- Revenue
- £10.7m
- Profit
- £596k
- Staff
- 34
- Itf Pharma LtdLondon · Wholesale of pharmaceutical goods
- Revenue
- £3.6m
- Profit
- £320k
- Staff
- 9
Sources
Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £348k), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.